The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA

Psychopharmacology

Volumn 127, Issue 1, 1996, Pages 19-24

  Paslawski, Teresa ^a   Treit, Dallas ^a   Baker, Glen B ^a   George, Monica ^a   Coutts, Ronald T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Antipanic; Anxiolytic; GABA; Phenelzine; Plus maze

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; AMINE OXIDASE (FLAVIN CONTAINING); ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; DRUG METABOLITE; MONOAMINE OXIDASE INHIBITOR; N2 ACETYLPHENELZINE; PHENELZINE; UNCLASSIFIED DRUG;

4 AMINOBUTYRIC ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; TRANQUILIZING ACTIVITY;

EID: 0029815729     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02805970     Document Type: Article

References (43)

1. Baker GB, Wong JT, Yeung JM, Coutts RT (1991) Effects of the antidepressant phenelzine on brain levels of γ-aminobutyric acid (GABA). J Affect Dis 21:207-211
2. Beardslee SL, Papadakis E, Fontana DJ, Commissaris RL (1990) Antipanic drug treatments: failure to exhibit anxiolytic-like effects on defensive burying behavior. Pharmacol Biochem Behav 35:451-455
3. Briley M, Chopin P, Veigner M (1986) The plus-maze test of anxiety: validation in different rat strains and effect of a wide range of antidepressants. Br J Pharmacol 87:217P
4. Cassella JV, Davis M (1985) Fear-enhanced acoustic startle is not attenuated by acute or chronic imipramine treatment in rats. Psychopharmacology 87:278-282
5. Cole JC, Rodgers RJ (1995) Ethological comparisons of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze. Pharmacol Biochem Behav 52:473-478
6. Commissaris RL, Humrich J, Johns J, Geere DG, Fontana J (1995) The effects of selective and non-elective monoamine oxidase (MAO) inhibitors on conflict behavior in the rat. Behav Pharmacol 6:195-202
7. Corbett R, Fielding S Cornfeldt M, Dunn RW (1991) GABAmimetic agents display anxiolytic-like effects in the social interaction and elevated plus maze procedures. Psychopharmacology 104:312-316
8. Costall B, Jones BJ, Kelley ME, Naylor RJ, Tomkins DM (1989) Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol Biochem Behav 15:695-699
9. Coutts RT, Mozayani A, Pasutto FM, Baker GB, Danielson TJ (1990) Synthesis and pharmacological evaluation of acyl derivatives of phenelzine. Res Commun Chem Path Pharmacol 67: 3-15
10. Crawley JN (1981) Neuropharmacological specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacol Biochem Behav 15:695-699
11. Cuomo V, Cagiano R, De Saliva MA, Maselli MA, Renna G, Racagni G (1988) Ultrasonic vocalization in response to unavoidable aversive stimuli in rats: effects of benzodiazepines. Life Sci 43:485-491
12. Danielson TJ, Coutts RT, Baker GB, Rubens M (1984) Studies in vivo and in vitro on N-acetylphenelzine. Proc West Pharmacol Soc 27:507-510
13. File SE (1987) The contribution of behavioural studies to the neuropharmacology of anxiety. Neuropharmacology 26:877-886
14. File SE, Johnston AL (1987) Chronic treatment with imipramine does not reverse the effects of three anxiogenic compounds in a test of anxiety in the rat. Neuropsychobiology 17: 187-192
15. Fontana DJ, Carbary TJ, Commissaris RL (1989) Effects of acute and chronic anti-panic drug administration on conflict behavior in the rat. Psychopharmacology 98:157-162
16. Gao B, Cutler MG (1994) Effects of acute and chronic administration of the antidepressants, imipramine, phenelzine and mianserin, on the social behavior of mice. Neuropharmacology 33:813-824
17. Gardner C (1985) Inhibition of ultrasonic distress vocalizations in rat pups by chlordiazepoxide and diazepam. Drug Dev Res 5:185-193
18. Handley S, McBlane JW (1992) Opposite effects of fluoxetine in two animal models of anxiety. Br J Pharmacol 107:446P
19. Johnston AL, File SE (1988) The profiles of the anti-panic compounds, triazolobenzodiazepines and phenelzine in two animal tests of anxiety. Psychiatry Res 25:81-90
20. Klein DF (1981) Anxiety reconceptualized. In: Klein DF, Rabkin JD (eds) Anxiety: new research and changing concepts. Raven Press, New York, pp 235-262
21. Lister RG (1990) Ethologically-based animal models of anxiety disorders. Pharmacol Ther 46:321-340
22. Lyles GA, Callingham BA (1982) In vitro and in vivo inhibition by benserazide of clorgyline-resistant amine oxidases in rat cardiovascular tissues. Biochem Pharmacol 31:1417-1424
23. Mason P, Skinner J, Luttinger D (1987) Two tests in rats for anti-anxiety effect of clinically anxiety attenuating antidepressants. Psychopharmacology 92:30-34
24. 2-Acetylphenelzine: effects on rat brain GABA, alanine and biogenic amines. Naunyn-Schmiedeberg's Arch Pharmacol 343:478-482
25. 2-adrenoreceptor function. J Pharm Sci 81:832-835
26. Nutt DJ, Glue P (1989) Clinical pharmacology of anxiolytics and antidepressants. A psychopharmacological perspective. Pharmacol Ther 44:309-344
27. Pellow S (1986) Anxiolytic and anxiogenic drug effects in a novel test of anxiety: are exploratory models of anxiety in rodents valid? Methods Find Exp Clin Pharmacol 8:557-565
28. Pellow S, File SE (1986) Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24:525-529
29. Pellow S, Chopin P, File SE, Briley M (1985) Validation of open:closed arm entries in the elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149-167
30. Pellow S, Johnston AL, File SE (1987) Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat. J Pharm Pharmacol 39:917-928
31. Pesold C, Treit D (1995) The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res 671:213-221
32. Rickels K, Downing R, Schweizer E, Hassman H (1993) Antidepressants for the treatment of generalized anxiety disorder. Arch Gen Psychiatry 50:884-895
33. Rodgers RJ, Cole JC (1994) The elevated plus-maze: pharmacology, methodology and ethology. In: Cooper SJ, Hendrie CA (eds) Ethology and psychopharmacology. Wiley, Chichester, pp 8-44
34. Sayin U, Purali N, Ozkan T, Altug T, Buyukdevrim S (1992) Vigabatrin has an anxiolytic effect in the elevated plus-maze test of anxiety. Pharmacol Biochem Behav 43:529-535
35. Sheehan DV (1985) Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia. Psychiatric Clin N Am 8:49-62
36. Sheehan DV (1986) Tricyclic antidepressants in the treatment of panic and anxiety disorders. Psychosomatics 27:10-16
37. Sloley BD, Kah D, Trudeau VL Delka JG, Peter RE (1992) Amino acid neurotransmitters and dopamine in brain and pituitary of the goldfish: involvement of gonadotropin secretion. J Neurochem 58:2254-2262
38. Tallman JF, Gallager DW (1985) The GABA-ergic system: a locus of benzodiazepine action Annu Rev Neurosci 8:21-44
39. A receptor subunit gene expression in rat brain. Br J Pharmacol 117:15p
40. Treit D (1985) Animal models for the study of anti-anxiety agents: a review. Neurosci Biobehav Rev 9:203-222
41. Treit D (1994) Animal models of anxiety and anxiolytic drug action. In: den Boer JA, Ad Sitzen JM (eds) Handbook of depression and anxiety: a biological approach. Marcel Dekker. New York, pp 201-224
42. Treit D, Pinel JPJ, Fibiger HC (1981) Conditioned defensive burying: A new paradigm for the study of anxiolytic agents. Pharmacol Biochem Behav 15:619-626
43. Zorumski CF, Isenberg KE (1991) Insights into the structure and function of GABA-benzodiazepine receptors: ion channels and psychiatry. Am J Psychiatry 148: 162-173